History | Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 144 KB)

Published:

14 October 2020
Committee papers TA416 committee papers (PDF 12.42 MB)

Published:

14 October 2020
Committee papers TA416 committee papers (PDF 3.51 MB)

Published:

14 October 2020
Register of interests (PDF 345 KB)

Published:

14 October 2020

Final draft guidance

Final draft guidance
Final appraisal document (PDF 213 KB)

Published:

11 September 2020
Public committee slides (PDF 822 KB)

Published:

11 September 2020
Committee papers (PDF 5.78 MB)

Published:

11 September 2020

Invitation to participate

Final stakeholder list (PDF 100 KB)

Published:

23 May 2019
Final scope (PDF 120 KB)

Published:

23 May 2019
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 126 KB)

Published:

23 May 2019